{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:13:40Z","timestamp":1793751220144,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Orchid, Fighting Male Cancer; Barts and the London charity","award":["487\/1786"],"award-info":[{"award-number":["487\/1786"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.humpath.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,10,27]],"date-time":"2019-10-27T10:10:58Z","timestamp":1572171058000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition"],"prefix":"10.1016","volume":"94","author":[{"given":"Glenda","family":"Scandura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Alifrangis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Shamash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.humpath.2019.10.004_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/andr.293","article-title":"International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007","volume":"3","author":"Trabert","year":"2015","journal-title":"Andrology"},{"issue":"Supplement","key":"10.1016\/j.humpath.2019.10.004_bb0010","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.4103\/jcrt.JCRT_916_16","article-title":"Adjuvant radiotherapy for stage I seminoma: a single-institutional experience","volume":"15","author":"Kanyilmaz","year":"2019","journal-title":"J Cancer Res Ther"},{"issue":"28","key":"10.1016\/j.humpath.2019.10.004_bb0015","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2012.47.6010","article-title":"Active surveillance is the preferred approach to clinical stage I testicular cancer","volume":"31","author":"Nichols","year":"2013","journal-title":"J Clin Oncol"},{"issue":"90","key":"10.1016\/j.humpath.2019.10.004_bb0020","article-title":"Pure seminoma: a review and update","volume":"6","author":"Boujelbene","year":"2011","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.humpath.2019.10.004_bb0025","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","article-title":"A nationwide cohort study of stage I seminoma patients followed on a surveillance program","volume":"66","author":"Mortensen","year":"2014","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.humpath.2019.10.004_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/his.13667","article-title":"Pathological risk factors for higher clinical stage in testicular seminomas","volume":"73","author":"Trevino","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2019.10.004_bb0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.eururo.2017.09.025","article-title":"Testicular tumor size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: a systematic review by the Testicular Cancer Guidelines Panel","volume":"73","author":"Boormans","year":"2017","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.humpath.2019.10.004_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.urolonc.2017.06.047","article-title":"Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance\u2014a systematic review","volume":"36","author":"Zengerling","year":"2018","journal-title":"Urol Oncol"},{"issue":"35","key":"10.1016\/j.humpath.2019.10.004_bb0045","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2011.36.0503","article-title":"Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study","volume":"29","author":"Aparicio","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2019.10.004_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.humpath.2019.10.004_bb0055","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00432-016-2162-z","article-title":"Testicular seminoma clinical stage 1: treatment outcome on a routine care level","volume":"142","author":"Dieckmann","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.humpath.2019.10.004_bb0060","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.1992.164","article-title":"Surveillance following orchidectomy for stage I testicular seminoma","volume":"65","author":"Horwich","year":"1992","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.humpath.2019.10.004_bb0065","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1442-2042.2010.02645.x","article-title":"Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients","volume":"17","author":"Kamba","year":"2010","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.humpath.2019.10.004_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/COC.0b013e318277d839","article-title":"Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort","volume":"37","author":"Soper","year":"2014","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.humpath.2019.10.004_bb0075","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2010.30.1044","article-title":"Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group","volume":"29","author":"Tandstad","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.humpath.2019.10.004_bb0080","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/annonc\/mdw164","article-title":"Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)","volume":"27","author":"Tandstad","year":"2016","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2019.10.004_bb0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.urology.2007.05.020","article-title":"Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma","volume":"70","author":"Valdevenito","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.humpath.2019.10.004_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1464-410x.1999.00048.x","article-title":"The value of central histopathological review of testicular tumors before treatment","volume":"84","author":"Lee","year":"1999","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.humpath.2019.10.004_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2559.2005.02207.x","article-title":"The continued value of central histopathological review of testicular tumors","volume":"47","author":"Delaney","year":"2005","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.humpath.2019.10.004_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAP.0b013e318159475d","article-title":"The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them","volume":"15","author":"Ulbright","year":"2008","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2019.10.004_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clgc.2016.05.005","article-title":"Value of supraregional multidisciplinary review for the contemporary management of testicular tumors","volume":"15","author":"Purshouse","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2019.10.004_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.humpath.2019.10.004_bb0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/his.13115","article-title":"The World Health Organization 2016 classification of testicular non-germ cell tumors: a review and update from the International Society of Urological Pathology Testis Consultation Panel","volume":"70","author":"Idrees","year":"2017","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.humpath.2019.10.004_bb0120","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1097\/PAS.0000000000001049","article-title":"Intraoperative consultation and macroscopic handling: the International Society of Urological Pathology (ISUP) testicular cancer consultation conference recommendations","volume":"42","author":"Verrill","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2019.10.004_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.13200","article-title":"UICC drops the ball in the 8th edition TNM staging of urological cancers","volume":"71","author":"Delahunt","year":"2017","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.humpath.2019.10.004_bb0130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.urology.2005.09.050","article-title":"Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002","volume":"67","author":"Tyldesley","year":"2006","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.humpath.2019.10.004_bb0135","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/cncr.30458","article-title":"Surveillance versus adjuvant radiotherapy for patients with high-risk stage I seminoma","volume":"123","author":"Mortensen","year":"2017","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.humpath.2019.10.004_bb0140","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.humpath.2019.10.004_bb0145","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Algaba F, et al. Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"issue":"22","key":"10.1016\/j.humpath.2019.10.004_bb0150","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.humpath.2019.10.004_bb0155","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/annonc\/mdu437","article-title":"Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)","volume":"25","author":"Aparicio","year":"2014","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.humpath.2019.10.004_bb0160","first-page":"762","article-title":"Spermatic cord contamination in testicular cancer","volume":"9","author":"Nazeer","year":"1996","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2019.10.004_bb0165","volume":"41","author":"Clare Verrill","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2019.10.004_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2016.07.013","article-title":"Conditional risk of relapse in surveillance for clinical stage I testicular cancer","volume":"71","author":"Nayan","year":"2017","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.humpath.2019.10.004_bb0175","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1442-2042.2009.02355.x","article-title":"Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome","volume":"16","author":"Yoshida","year":"2009","journal-title":"Int J Urol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:42:50Z","timestamp":1576197770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719301807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"alternative-id":["S0046817719301807"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.10.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}